Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
49.87 USD | +2.80% | +3.25% | -40.27% |
Jun. 03 | Cytokinetics Insider Sold Shares Worth $635,978, According to a Recent SEC Filing | MT |
May. 29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 57.89 | 108.06 | 93.73 |
Spread/Res. | -13.85% | -53.85% | -46.79% |
Spread/Supp. | +4.20% | +53.16% | +69.28% |
Support | 47.86 | 32.56 | 29.46 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CYTK Stock
- Charts Cytokinetics, Incorporated